These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38971714)

  • 1. [Balancing drug regulation and health democracy: The role of patient and healthcare professional advisors at the ANSM].
    Maison P; Bacon T; Daynes P; Decoene C; Mazet R; Vial T; Vignot S; Belgodère L; Oualikene-Gonin W; Ratignier-Carbonneil C
    Therapie; 2024 Jun; ():. PubMed ID: 38971714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of involving patients and public in health services research and evaluation: a qualitative study.
    Saini P; Hassan SM; Morasae EK; Goodall M; Giebel C; Ahmed S; Pearson A; Harper LM; Cloke J; Irvine J; Gabbay M
    Res Involv Engagem; 2021 Jun; 7(1):49. PubMed ID: 34187590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Civil society involvement in harm reduction drug policy: reflections on the past, expectations for the future.
    O'Gorman A; Schatz E
    Harm Reduct J; 2021 Feb; 18(1):17. PubMed ID: 33568156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [From being given a voice to representation, the role of the users in the health care system].
    Compagnon C
    Soins; 2015 Jun; (796):26-8. PubMed ID: 26146318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Explanation of context, mechanisms and outcomes in adult community mental health crisis care: the MH-CREST realist evidence synthesis.
    Clibbens N; Baker J; Booth A; Berzins K; Ashman MC; Sharda L; Thompson J; Kendal S; Weich S
    Health Soc Care Deliv Res; 2023 Sep; 11(15):1-161. PubMed ID: 37837344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A proposal for reforming psychologists' training in France and in the European Union].
    Bouchard JP
    Encephale; 2009 Feb; 35(1):18-24. PubMed ID: 19250989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention and management of health products shortages by the French national agency (ANSM), 10 years of experience.
    Belgodère L; Emmerich J; Albin N; Bacon T; Daynes P; Vignot S; Vial T; Renaud G; Le Saulnier C; Maillard-Couvreur C; Cachet M; Veyries ML; Youdarene R; Oualikene-Gonin W; Ratignier-Carbonneil C; Maison P
    Front Public Health; 2023; 11():1293110. PubMed ID: 38045969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [From psychoactive medicines to addictovigilance in French Public Health Code (1990-2017)].
    Baumevieille M; Perri-Plandé J; Miremont-Salamé G; Daveluy A; Haramburu F
    Therapie; 2019 Jun; 74(3):375-382. PubMed ID: 30193805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory assessment of nano-enabled health products in public health interest. Position of the scientific advisory board of the French National Agency for the Safety of Medicines and Health Products.
    Oualikene-Gonin W; Sautou V; Ezan E; Bastos H; Bellissant E; Belgodère L; Maison P; Ankri J;
    Front Public Health; 2023; 11():1125577. PubMed ID: 36935690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Civil society advocacy in Nigeria: promoting democratic norms or donor demands?
    Williamson RT; Rodd J
    BMC Int Health Hum Rights; 2016 Jul; 16(1):19. PubMed ID: 27400871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain health and value diversity: A new implementation field for values-based practice?
    Alexopoulos P; Canty A; Dasgupta J; Furlano JA; Nogueira Haas A
    Psychiatriki; 2024 Mar; 35(1):13-16. PubMed ID: 38252899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The congress of the French Society of Pharmacology and Therapeutics celebrate in Nancy, 20 April 2016, 40 years of French Regional Pharmacovigilance Centres!].
    Jonville-Béra AP; Mallaret M; Sgro C;
    Therapie; 2016 Sep; 71(4):351-4. PubMed ID: 27296805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The blind spots of psychiatric reform in Greece.
    Stylianidis S
    Psychiatriki; 2024 Jun; 35(2):99-102. PubMed ID: 38814270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Japan as the front-runner of super-aged societies: Perspectives from medicine and medical care in Japan.
    Arai H; Ouchi Y; Toba K; Endo T; Shimokado K; Tsubota K; Matsuo S; Mori H; Yumura W; Yokode M; Rakugi H; Ohshima S
    Geriatr Gerontol Int; 2015 Jun; 15(6):673-87. PubMed ID: 25656311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advocacy for health equity: a synthesis review.
    Farrer L; Marinetti C; Cavaco YK; Costongs C
    Milbank Q; 2015 Jun; 93(2):392-437. PubMed ID: 26044634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peer, professional, and public: an analysis of the drugs policy advocacy community in Europe.
    O'Gorman A; Quigley E; Zobel F; Moore K
    Int J Drug Policy; 2014 Sep; 25(5):1001-8. PubMed ID: 24974366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.